SeaStar Medical Holding Corporation
ICU
$0.56
-$0.01-2.60%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -16.74% | 5.92% | 5.16% | -21.82% | -18.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.91% | 31.67% | 24.76% | -14.27% | -17.50% |
| Operating Income | -0.70% | -28.56% | -23.82% | 14.63% | 17.50% |
| Income Before Tax | 55.04% | 50.05% | 5.36% | -18.71% | -64.59% |
| Income Tax Expenses | 250.00% | -- | -- | -140.00% | -133.33% |
| Earnings from Continuing Operations | 55.03% | 50.04% | 5.34% | -18.68% | -64.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.03% | 50.04% | 5.34% | -18.68% | -64.53% |
| EBIT | -0.70% | -28.56% | -23.82% | 14.63% | 17.50% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 87.52% | 85.58% | 76.42% | 71.53% | 51.51% |
| Normalized Basic EPS | 82.45% | 80.72% | 71.10% | 66.73% | 65.51% |
| EPS Diluted | 87.52% | 85.58% | 76.42% | 71.53% | 51.51% |
| Normalized Diluted EPS | 82.45% | 80.72% | 71.10% | 66.73% | 65.51% |
| Average Basic Shares Outstanding | 253.76% | 269.27% | 328.57% | 384.92% | 341.71% |
| Average Diluted Shares Outstanding | 253.76% | 269.27% | 328.57% | 384.92% | 341.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |